Transcode Therapeutics Funding: $45M Raised, Growth (2026)

Transcode Therapeutics is based in Boston, MA. It has raised $45M in total funding. Latest round: Growth.

Transcode Therapeutics funding overview

Transcode Therapeutics is based in Boston, MA. Transcode Therapeutics has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in April 2026. The round record for Transcode Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include CK Life Sciences Int'l., Institutional healthcare investor. 2 distinct backers are named across the disclosed rounds.

Transcode Therapeutics at a glance

Total raised
$45M
Latest round
Growth
Latest round date
April 2026
Headquarters
Boston, MA
Notable investors
CK Life Sciences Int'l., Institutional healthcare investor

Frequently asked about Transcode Therapeutics funding

How much has Transcode Therapeutics raised?
Transcode Therapeutics has raised $45M in total disclosed funding across the rounds on record.
Who has invested in Transcode Therapeutics?
CK Life Sciences Int'l., Institutional healthcare investor are named among the investors backing Transcode Therapeutics.
What was the latest Transcode Therapeutics funding round?
The most recent disclosed round is a Growth, announced in April 2026.
Where is Transcode Therapeutics based?
Transcode Therapeutics is based in Boston, MA.
When did Transcode Therapeutics last raise?
The last disclosed Transcode Therapeutics round closed in April 2026 at Growth.

Every Transcode Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Boston at a similar stage.

Transcode Therapeutics pitch deck

The investor deck Transcode Therapeutics used to raise — 2022, Public (NASDAQ: RNAZ), 44-slide deck is broken down slide by slide, including the slides it leads with and the questions it leaves open.

Companies related to Transcode Therapeutics (18)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades